Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

557
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
557
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

483
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
483
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

526
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
526
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

439
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
439
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

599
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
599
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

354
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
354

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antenatal Care as a Strategic Window for Long-Term Cardiovascular Risk Assessment.

JACC. Advances·2026
Same author

Lipoprotein(a), Inflammation, and Risk of Coronary Artery Disease and Aortic Valve Stenosis.

JAMA cardiology·2026
Same author

Gestational Glucose Intolerance and the Risk of Hypertensive Disorders of Pregnancy.

Journal of the American Heart Association·2026
Same author

Hormonal context and lipoprotein(a)-associated venous thromboembolism risk.

European heart journal·2026
Same author

Mutation-dependent responses to sleep and exercise in clonal haematopoiesis.

Nature·2026
Same author

Impact of kidney ischemic time on two-year survival and graft outcomes after simultaneous heart-kidney transplantation: Analysis of the OPTN registry.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Related Experiment Video

Updated: Jan 30, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.5K

Peripartum cardiomyopathy.

Michael C Honigberg1,2, Michael M Givertz3,2

  • 1Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA.

BMJ (Clinical Research Ed.)
|February 1, 2019
PubMed
Summary
This summary is machine-generated.

Peripartum cardiomyopathy (PPCM) affects women during pregnancy or postpartum. While some recover, others face chronic heart issues, with bromocriptine under investigation as a treatment.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.4K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.0K

Related Experiment Videos

Last Updated: Jan 30, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

1.5K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.4K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.0K

Area of Science:

  • Cardiology
  • Obstetrics
  • Genetics

Background:

  • Peripartum cardiomyopathy (PPCM) is a rare systolic dysfunction affecting women in late pregnancy or postpartum.
  • Black women, those with pre-eclampsia, advanced maternal age, or multiple gestations face higher risks.
  • The pathophysiology involves vasculo-hormonal pathways and potentially sarcomere gene mutations.

Purpose of the Study:

  • To review current literature on peripartum cardiomyopathy.
  • To identify knowledge gaps and future research directions for PPCM.

Main Methods:

  • Literature review of peripartum cardiomyopathy.

Main Results:

  • Over half of affected women recover systolic function.
  • Complications include chronic cardiomyopathy, thromboembolism, and arrhythmia.
  • Standard heart failure treatments are used, with bromocriptine being investigated.

Conclusions:

  • PPCM pathophysiology requires further elucidation.
  • Research should focus on understanding underlying susceptibility and developing targeted treatments.
  • Improved management strategies are needed for pregnant and postpartum women with PPCM.